Shay Capital LLC Pharma Cyte Biotech, Inc. Transaction History

Shay Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$2.24 - $2.85 $73,848 - $93,958	32,968 Added 3.35%	1,015,666 $2.44 Million
Q2 2022 Aug 15, 2022	BUY	$1.99 - $2.33 $75,683 - $88,614	38,032 Added 4.03%	982,698 $2.2 Million
Q1 2022 May 16, 2022	BUY	$1.91 - $2.77 $539,248 - $782,051	282,329 Added 42.63%	944,666 $2.17 Million
Q4 2021 Feb 14, 2022	BUY	$2.4 - $3.19 $1.55 Million - $2.07 Million	647,731 Added 4434.69%	662,337 $1.66 Million
Q3 2021 Nov 15, 2021	BUY	$2.28 - $16.9 $33,301 - $246,841	14,606 New	14,606 $46,000

1.07M

5.4K

400

Ticker PMCB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,750,100
Market Cap $41.5M
Description
PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types o...

Get notified when there are updates to the investment portfolio of Shay Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Shay Capital LLC with notifications on news.